Coughlin Timothy P
SEC-identified person · CIK 1376043 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | Director | filed 2015 - 2026 |
| Vir Biotechnology, Inc. VIR | Director | filed 2026 - 2026 |
| ADC Therapeutics SA ADCT | Director | filed 2025 - 2026 |
| Atyr Pharma INC LIFE | Director | filed 2017 - 2026 |
| Fate Therapeutics INC fate | Director | filed 2013 - 2024 |
| Neurocrine Biosciences INC NBIX | VP and Chief Financial Officer | filed 2006 - 2017 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.